ACT Genomics Singapore

Established in 2015, ACT Genomics Singapore is the first subsidiary of ACT Genomics. We are a cancer molecular information service company working together with experts with several years’ experience in oncology, cancer genomics, and bioinformatics. 

Our team is made up of a group of highly dedicated specialists in various domains, such as cancer biology, next-generation sequencing, bio- and medical informatics, to turn genomics into action. Our company’s state-of-the-art technological capacity provides the possibility to transform cancer genomic information into precision diagnosis and personalized treatments. We look forward to collaborating with physicians and cancer patients to improve the quality of life of cancer patients and make cancer manageable.